Salivary CRP kit in early diagnosis of cancer

Not Applicable

• Conditions: Health Condition 1: C069- Malignant neoplasm of mouth, unspecified

• Registration Number: CTRI/2023/06/053470
• Lead Sponsor: Department of Oral Medicine and Radiology Manipal College of Dental Science Manipal Manipal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Male and Female patients with age greater than 18 years with potentially malignant lesions like( Erosive Variant of lichen planus, leukoplakia, erythroplakia, Oral Submucous Fibrosis) and Oral malignancies.

Patients who agree to participate in the study

Inclusion criteria for control- age and gender matched non habituated, otherwise healthy individuals visiting dental opd clinics for dental problems, with healthy oral mucosa.

Exclusion Criteria

Patients with any chronic systemic diseases like Diabetes Mellitus, inflammatory bwel disease or autoimmune disorders like arthritis will not be included for the study

Patients who are on drugs like corticosteroids which can alter the level of CRP will be excluded from the study

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The outcome from this study will be baselinevalue for salivary C reactive protein which can be used for diagnosing potentially malignant changes & malignant lesions & its disease progression.Timepoint: at baseline 4 weeks 8 weeks 12 weeks 16 weeks 20 weeks 24 weeks

Secondary Outcome Measures

Name	Time	Method
ong term outcome of the study is early detection of malignant & premalignant lesions & the mass detection of the sameTimepoint: at base line 12 weeks 24 weeks & every 6 months after the study for 1 year